Centre d'Investigation Clinique - UF 1042 - CHRU Strasbourg - Nouvel Hôpital Civil
- Address
- lock Available on a paid plan
Female Urogenital and Pregnancy-Related Research
At the Centre d'Investigation Clinique - UF 1042 - CHRU Strasbourg - Nouvel Hôpital Civil, clinical research in female urogenital diseases and pregnancy complications focuses on women with recurrent implantation failure. The studies are designed to assess whether a new treatment approach can improve the chances of achieving a clinical pregnancy.
- Women with unexplained recurrent implantation failure
- Female urogenital and pregnancy-related conditions
- Testing treatment effectiveness for improving pregnancy outcomes
This work reflects a strong interest in reproductive health and in finding better options for patients facing repeated implantation difficulties.
Immune and Respiratory Disease Trials
Research at this CHRU Strasbourg site also covers immune system diseases and respiratory tract diseases, with a focus on severe asthma. The trial activity is aimed at understanding whether continuing or stopping an established treatment strategy offers the best long-term control for patients.
- Severe asthma
- Immune system and respiratory disease research
- Evaluating treatment durability and disease control
The studies are intended to support better management choices for people living with persistent asthma that remains under control with ongoing therapy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre d'Investigation Clinique - UF 1042 - CHRU Strasbourg - Nouvel Hôpital Civil
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Certolizumab Pegol in Adult Women with Unexplained Recurrent Implantation Failure: A Double-Blind, Randomized, Placebo-Controlled Trial | Assistance Publique Hopitaux De Paris | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Certolizumab Pegol | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.